Dr. John William Dubay, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 809 University Blvd E, Dch Cancer Treatment Center, Tuscaloosa, AL 35401 Phone: 205-759-7803 Fax: 205-343-8029 |
Dr. Tatyana Sycheva, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1400 Afflink Pl, Suite 100, Tuscaloosa, AL 35406 Phone: 205-366-9740 Fax: 205-344-9992 |
Pamela Hughes, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-759-7800 Fax: 205-343-8029 |
Dr. Alejandro Garcia-hernandez, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1410 Mcfarland Blvd N, Tuscaloosa, AL 35406 Phone: 205-345-8208 Fax: 205-345-8209 |
Dr. Kathryn A Arrambide, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1410 Mcfarland Blvd N, Tuscaloosa, AL 35406 Phone: 205-345-8208 Fax: 205-345-8209 |
News Archive
The U.S. Food and Drug Administration recently announced the authorization of FerriScan R2-MRI to be marketed as an imaging companion diagnostic device for the safe and effective use of Exjade in patients with non-transfusion-dependent thalassemia.
One of the most devastating side effects of diabetes is kidney failure, and one of the earliest signs of kidney damage is a disruption of the organ's filtering capacity. Diabetes patients who develop kidney failure must go on dialysis, seriously limiting their quality of life and placing them at significantly increased risk of death. The incidence of kidney disease is increasing with rising rates of obesity-associated type 2 diabetes, but very little progress has been made towards protecting the kidney's filter barrier during the past 50 years.
To help aspiring nurses in Alabama whose nursing education may have been interrupted by the tornado disasters last month, Kaplan Nursing is offering its NCLEX-RN Review Class for free, Monday, May 23 through Thursday, May 26, from 9 AM to 4 PM, at Wallace State Community College in Hanceville.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and Regensburg University, both in Germany, and the University of Lisboa, in Portugal, have discovered a promising potential drug target for cystic fibrosis.
› Verified 8 days ago